A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...

The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain treatment. Suzetrigine is the first non-opioid analgesic – or ...

The Food and Drug Administration this week approved a new type of painkiller that doesn’t carry the risk of addiction or overdose associated with opioid medications. The drug, suzetrigine, will ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, the first new class of pain medication in more than two decades. Developed by Vertex Pharmaceuticals, the drug-known generically as ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...

CLEVELAND, OH (CLEVELAND CLINIC) - Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, which was just approved by the FDA, could ...

(ABC 6 News) — The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid. The drug is called Journavx, and it is taken orally twice per day.